
Please try another search
Some stocks were punished by the market despite satisfactory results. In hindsight, it looks like investors have overreacted to earnings that weren't so bad. Could this be a buying opportunity? In...
The cannabis sector experienced significant growth in 2019 but then went on to decline eventually. However, the sector is now experiencing a robust resurgence this year, driven by rumors that the DEA...
The magnificent 7 have dominated the headlines in the past couple of years. Small and mid-cap stocks have struggled amid a high-interest-rate environment, but signs of recovery emerged at the end of...
Demand for natural gas in Europe is falling, and a peak in LNG prices is on the horizon. Warmer-than-expected winter, and increased supply diversification favor price declines as well. As a result,...
Eli Lilly's ascent in late January, driven by the success of its weight-loss drug Zepbound, ousted Tesla from Wall Street's Magnificent 7. Analysts are predicting the company's value to exceed $900...
Nvidia is scheduled to report fiscal fourth-quarter earnings after the bell on Wednesday. Excitement over the business potential of AI has boosted its shares by 40% this year. NVDA stock could see a...
The P/E ratio is a crucial metric for investors, providing insight into how much they're willing to pay for each dollar of a company's earnings. Currently, the S&P 500 is trading at more than 20...
ProPicks, Investing.com's flagship AI-powered investment tool, consistently outperforms benchmarks like the S&P 500 with meticulously analyzed high-performing stocks. With six robust strategies,...